Cargando…

Distinct MicroRNA Profiles in the Perilymph and Serum of Patients With Menière's Disease

Hypothesis: Menière's disease microRNA (miRNA) profiles are unique and are reflected in the perilymph and serum of patients. Background: Development of effective biomarkers for Menière's disease are needed. miRNAs are small RNA sequences that downregulate mRNA translation and play a signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Shew, Matthew, Wichova, Helena, St. Peter, Madeleine, Warnecke, Athanasia, Staecker, Hinrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242941/
https://www.ncbi.nlm.nih.gov/pubmed/34220670
http://dx.doi.org/10.3389/fneur.2021.646928
_version_ 1783715667665485824
author Shew, Matthew
Wichova, Helena
St. Peter, Madeleine
Warnecke, Athanasia
Staecker, Hinrich
author_facet Shew, Matthew
Wichova, Helena
St. Peter, Madeleine
Warnecke, Athanasia
Staecker, Hinrich
author_sort Shew, Matthew
collection PubMed
description Hypothesis: Menière's disease microRNA (miRNA) profiles are unique and are reflected in the perilymph and serum of patients. Background: Development of effective biomarkers for Menière's disease are needed. miRNAs are small RNA sequences that downregulate mRNA translation and play a significant role in a variety of disease states, ultimately making them a promising biomarker. miRNAs can be readily isolated from human inner ear perilymph and serum, and may exhibit disease-specific profiles. Methods: Perilymph sampling was performed in 10 patients undergoing surgery; 5 patients with Meniere's disease and 5 patients with otosclerosis serving as controls. miRNAs were isolated from the serum of 5 patients with bilateral Menière's disease and compared to 5 healthy age-matched controls. For evaluation of miRNAs an Agilent miRNA gene chip was used. Analysis of miRNA expression was carried out using Qlucore and Ingenuitey Pathway Analysis software. Promising miRNAs biomarkers were validated using qPCR. Results: In the perilymph of patients with Menière's disease, we identified 16 differentially expressed miRNAs that are predicted to regulate over 220 different cochlear genes. Six miRNAs are postulated to regulate aquaporin expression and twelve miRNAs are postulated to regulate a variety of inflammatory and autoimmune pathways. When comparing perilymph with serum samples, miRNA-1299 and−1270 were differentially expressed in both the perilymph and serum of Ménière's patients compared to controls. Further analysis using qPCR confirmed miRNA-1299 is downregulated over 3-fold in Meniere's disease serum samples compared to controls. Conclusions: Patients with Ménière's disease exhibit distinct miRNA expression profiles within both the perilymph and serum. The altered perilymph miRNAs identified can be linked to postulated Ménière's disease pathways and may serve as biomarkers. miRNA-1299 was validated to be downregulated in both the serum and perilymph of Menière's patients.
format Online
Article
Text
id pubmed-8242941
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82429412021-07-01 Distinct MicroRNA Profiles in the Perilymph and Serum of Patients With Menière's Disease Shew, Matthew Wichova, Helena St. Peter, Madeleine Warnecke, Athanasia Staecker, Hinrich Front Neurol Neurology Hypothesis: Menière's disease microRNA (miRNA) profiles are unique and are reflected in the perilymph and serum of patients. Background: Development of effective biomarkers for Menière's disease are needed. miRNAs are small RNA sequences that downregulate mRNA translation and play a significant role in a variety of disease states, ultimately making them a promising biomarker. miRNAs can be readily isolated from human inner ear perilymph and serum, and may exhibit disease-specific profiles. Methods: Perilymph sampling was performed in 10 patients undergoing surgery; 5 patients with Meniere's disease and 5 patients with otosclerosis serving as controls. miRNAs were isolated from the serum of 5 patients with bilateral Menière's disease and compared to 5 healthy age-matched controls. For evaluation of miRNAs an Agilent miRNA gene chip was used. Analysis of miRNA expression was carried out using Qlucore and Ingenuitey Pathway Analysis software. Promising miRNAs biomarkers were validated using qPCR. Results: In the perilymph of patients with Menière's disease, we identified 16 differentially expressed miRNAs that are predicted to regulate over 220 different cochlear genes. Six miRNAs are postulated to regulate aquaporin expression and twelve miRNAs are postulated to regulate a variety of inflammatory and autoimmune pathways. When comparing perilymph with serum samples, miRNA-1299 and−1270 were differentially expressed in both the perilymph and serum of Ménière's patients compared to controls. Further analysis using qPCR confirmed miRNA-1299 is downregulated over 3-fold in Meniere's disease serum samples compared to controls. Conclusions: Patients with Ménière's disease exhibit distinct miRNA expression profiles within both the perilymph and serum. The altered perilymph miRNAs identified can be linked to postulated Ménière's disease pathways and may serve as biomarkers. miRNA-1299 was validated to be downregulated in both the serum and perilymph of Menière's patients. Frontiers Media S.A. 2021-06-16 /pmc/articles/PMC8242941/ /pubmed/34220670 http://dx.doi.org/10.3389/fneur.2021.646928 Text en Copyright © 2021 Shew, Wichova, St. Peter, Warnecke and Staecker. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Shew, Matthew
Wichova, Helena
St. Peter, Madeleine
Warnecke, Athanasia
Staecker, Hinrich
Distinct MicroRNA Profiles in the Perilymph and Serum of Patients With Menière's Disease
title Distinct MicroRNA Profiles in the Perilymph and Serum of Patients With Menière's Disease
title_full Distinct MicroRNA Profiles in the Perilymph and Serum of Patients With Menière's Disease
title_fullStr Distinct MicroRNA Profiles in the Perilymph and Serum of Patients With Menière's Disease
title_full_unstemmed Distinct MicroRNA Profiles in the Perilymph and Serum of Patients With Menière's Disease
title_short Distinct MicroRNA Profiles in the Perilymph and Serum of Patients With Menière's Disease
title_sort distinct microrna profiles in the perilymph and serum of patients with menière's disease
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242941/
https://www.ncbi.nlm.nih.gov/pubmed/34220670
http://dx.doi.org/10.3389/fneur.2021.646928
work_keys_str_mv AT shewmatthew distinctmicrornaprofilesintheperilymphandserumofpatientswithmenieresdisease
AT wichovahelena distinctmicrornaprofilesintheperilymphandserumofpatientswithmenieresdisease
AT stpetermadeleine distinctmicrornaprofilesintheperilymphandserumofpatientswithmenieresdisease
AT warneckeathanasia distinctmicrornaprofilesintheperilymphandserumofpatientswithmenieresdisease
AT staeckerhinrich distinctmicrornaprofilesintheperilymphandserumofpatientswithmenieresdisease